Perform Another (Advanced) Search

1.  Study Posting (1918) Trial #158901, Leukemia, Savannah, GA
...to make Erwinase available to patients with acute lymphoblastic leukemia (ALL) who have had previous allergic reactions to certain formulations of L-asparaginase. Patient Inclusion Criteria: • Patient must give written informed consent ...
View Page

2.  Study Posting (4044) Trial #65923, Allergy, Quebec, Canada
...study are to assess: • The efficacy of Xolair in reducing the risk of peanut-induced allergic reactions in patients with chronic peanut allergy. The study will compare the peanut tolerability threshold in ...
View Page

3.  Study Posting (4044) Trial #65924, Allergy, Ontario, Canada
...study are to assess: • The efficacy of Xolair in reducing the risk of peanut-induced allergic reactions in patients with chronic peanut allergy. The study will compare the peanut tolerability threshold in ...
View Page

4.  Study Posting (4044) Trial #65913, Allergy, Various Cities, VA
...study are to assess: • The efficacy of Xolair in reducing the risk of peanut-induced allergic reactions in patients with chronic peanut allergy. The study will compare the peanut tolerability threshold in ...
View Page

5.  Study Posting (4044) Trial #65919, Allergy, Various Cities, PA
...study are to assess: • The efficacy of Xolair in reducing the risk of peanut-induced allergic reactions in patients with chronic peanut allergy. The study will compare the peanut tolerability threshold in ...
View Page

6.  Study Posting (4044) Trial #65917, Allergy, Various Cities, OH
...study are to assess: • The efficacy of Xolair in reducing the risk of peanut-induced allergic reactions in patients with chronic peanut allergy. The study will compare the peanut tolerability threshold in ...
View Page

7.  Study Posting (4044) Trial #65910, Allergy, Various Cities, NC
...study are to assess: • The efficacy of Xolair in reducing the risk of peanut-induced allergic reactions in patients with chronic peanut allergy. The study will compare the peanut tolerability threshold in ...
View Page

8.  Study Posting (4044) Trial #65918, Allergy, Various Cities, NY
...study are to assess: • The efficacy of Xolair in reducing the risk of peanut-induced allergic reactions in patients with chronic peanut allergy. The study will compare the peanut tolerability threshold in ...
View Page

9.  Study Posting (4044) Trial #83078, Allergy, Various Cities, NJ
...study are to assess: • The efficacy of Xolair in reducing the risk of peanut-induced allergic reactions in patients with chronic peanut allergy. The study will compare the peanut tolerability threshold in ...
View Page

10.  Study Posting (4044) Trial #65911, Allergy, Various Cities, NE
...study are to assess: • The efficacy of Xolair in reducing the risk of peanut-induced allergic reactions in patients with chronic peanut allergy. The study will compare the peanut tolerability threshold in ...
View Page

11.  Study Posting (4044) Trial #65921, Allergy, Various Cities, MN
...study are to assess: • The efficacy of Xolair in reducing the risk of peanut-induced allergic reactions in patients with chronic peanut allergy. The study will compare the peanut tolerability threshold in ...
View Page

12.  Study Posting (4044) Trial #65922, Allergy, Various Cities, MD
...study are to assess: • The efficacy of Xolair in reducing the risk of peanut-induced allergic reactions in patients with chronic peanut allergy. The study will compare the peanut tolerability threshold in ...
View Page

13.  Study Posting (4044) Trial #83079, Allergy, Various Cities, LA
...study are to assess: • The efficacy of Xolair in reducing the risk of peanut-induced allergic reactions in patients with chronic peanut allergy. The study will compare the peanut tolerability threshold in ...
View Page

14.  Study Posting (4044) Trial #65915, Allergy, Various Cities, FL
...study are to assess: • The efficacy of Xolair in reducing the risk of peanut-induced allergic reactions in patients with chronic peanut allergy. The study will compare the peanut tolerability threshold in ...
View Page

15.  Study Posting (4044) Trial #65916, Allergy, Various Cities, CO
...study are to assess: • The efficacy of Xolair in reducing the risk of peanut-induced allergic reactions in patients with chronic peanut allergy. The study will compare the peanut tolerability threshold in ...
View Page

16.  Study Posting (4044) Trial #65909, Allergy, Various Cities, CA
...study are to assess: • The efficacy of Xolair in reducing the risk of peanut-induced allergic reactions in patients with chronic peanut allergy. The study will compare the peanut tolerability threshold in ...
View Page

17.  Study Posting (4044) Trial #65914, Allergy, Various Cities, AR
...study are to assess: • The efficacy of Xolair in reducing the risk of peanut-induced allergic reactions in patients with chronic peanut allergy. The study will compare the peanut tolerability threshold in ...
View Page

18.  Study Posting (4044) Trial #65925, Allergy, Various Cities, United Kingdom
...study are to assess: • The efficacy of Xolair in reducing the risk of peanut-induced allergic reactions in patients with chronic peanut allergy. The study will compare the peanut tolerability threshold in ...
View Page

19.  Study Posting (3162) Trial #161438, Allergy, Rochester, NY
...E (IgE) is a protein that has been shown to play an important part in allergic reaction and the rush of events that result in allergic asthma. Xoliar® (omalizumab) is designed to ...
View Page

20.  Study Posting (2975) Trial #160114, Smoking Cessation, Lexington, KY
...year. • Must be in general good health. Exclusion Criteria : • Prior exposure to NicVax • Any known allergic reaction to any components of the vaccine' • Evidence or history of clinically significant allergic reactions • Previous ...
View Page